Michael Robinson, MD
VP & Therapeutic Area Head, Anterior Segment and Consumer Eye Care
Michael R. Robinson, MD, is a board-certified ophthalmologist who completed 3 years of post-doctoral/ fellowship training at the National Eye Institute with a focus on ocular drug delivery. Dr. Robinson joined Allergan in 2005 and currently serves as Vice President and Therapeutic Area Head of Anterior Segment and Consumer Eye Care. Given his broad clinical and research background, Dr. Robinson has served in multiple leadership roles at Allergan including Global Project Team Lead and Clinical Lead on projects related to ocular drug delivery in dry eye, retina and glaucoma therapeutic areas including the XEN Gel Stent. He has over 20 issued patents that include Bimatoprost SR and Brimonidine DDS, both in late stages of clinical development.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.